MAPK1 and neoplasm: Proteomic profiling further revealed its impact on multiple oncogenic and tumor-suppressive proteins, with notable upregulation of SERPINB2, KIT, and NOTCH1, alongside downregulation of COX2, DNMT1, MAPK1, AKT1, MKI67, EP300, and SMC1A.